Anzahl der Publikationen: 6
2022
Kaap-Fröhlich, Sylvia; Ulrich, Gert; Wershofen, Birgit; Ahles, Jonathan; Behrend, Ronja; Handgraaf, Marietta; Herinek, Doreen; Mitzkat, Anika; Oberhauser, Heidi; Scherer, Theresa; Schlicker, Andrea; Straub, Christine; Eichler, Regina Waury; Wesselborg, Baerbel; Witti, Matthias; Huber, Marion und Bode, Sebastin F. N.
(2022):
Position paper of the GMA Committee Interprofessional Education in the Health Professions current status and outlook.
In: GMS Journal for Medical Education, Bd. 39, Nr. 2, Doc17
2021
Masouris, Ilias; Manz, Kirsi ORCID: https://orcid.org/0000-0002-7740-4076; Pfirrmann, Markus; Dreyling, Martin; Angele, Barbara; Straube, Andreas; Langer, Sigrid; Huber, Marion; Koedel, Uwe und Baumgarten, Louisa von
(26. März 2021):
CXCL13 and CXCL9 CSF Levels in Central Nervous System Lymphoma-Diagnostic, Therapeutic, and Prognostic Relevance.
In: Frontiers in Neurology, Bd. 12, 654543
[PDF, 1MB]
2019
Mulazzani, Matthias; Huber, Marion; Borchard, Sabine; Langer, Sigrid; Angele, Barbara; Schuh, Elisabeth; Meinl, Edgar; Dreyling, Martin; Birnbaum, Tobias; Straube, Andreas; Ködel, Uwe und Baumgarten, Louisa von
(2019):
APRIL and BAFF: novel biomarkers for central nervous system lymphoma.
In: Journal of Hematology & Oncology, Bd. 12, Nr. 1, 102
2018
2017
Thaler, Franziska S.; Laurent, Sarah A.; Huber, Marion; Mulazzani, Matthias; Dreyling, Martin; Ködel, Uwe; Kümpfel, Tania; Straube, Andreas; Meinl, Edgar und Baumgarten, Louisa von
(2017):
Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.
In: Neuro-Oncology, Bd. 19, Nr. 12: S. 1618-1627
2016
Schönecker, Sonja; Brendel, Matthias; Huber, Marion; Vollmar, Christian; Huppertz, Hans-Juergen; Teipel, Stefan; Okamura, Nobuyuki; Levin, Johannes; Rominger, Axel und Danek, Adrian
(2016):
Applied multimodal diagnostics in a case of presenile dementia.
In: BMC Neurology
16:131
[PDF, 1MB]
Diese Liste wurde am
Sat Nov 23 22:00:49 2024 CET
erstellt.